Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.63 |
| ▸ | TYR | P14679 | 2/20 | 0.61 |
| ▸ | SLC5A2 | P31639 | 4/20 | 0.57 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 3/20 | 0.57 |
| ▸ | CA9 | Q16790 | 3/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11157080 | 0.91 | TYR (0.68) | POLBTYRCA12CA9CA1 | |
| SCHEMBL16788364 | 0.91 | TYR (0.68) | POLBTYRCA12CA9CA1 | |
| SCHEMBL17366541 | 0.91 | TYR (0.68) | POLBTYRCA12CA9CA1 | |
| SCHEMBL16785944 | 0.91 | TYR (0.68) | POLBTYRCA12CA9CA1 | |
| SCHEMBL20306177 | 0.91 | TYR (0.68) | POLBTYRCA12CA9CA1 | |
| SCHEMBL13964550 | 0.86 | POLB (0.64) | POLBEPHX2TYRCA12CA9 | |
| SCHEMBL13964551 | 0.86 | POLB (0.64) | POLBEPHX2TYRCA12CA9 | |
| SCHEMBL8656135 | 0.86 | TYR (0.69) | POLBTYRSLC28A3 | |
| SCHEMBL8656862 | 0.86 | TYR (0.69) | POLBTYRSLC28A3 | |
| SCHEMBL8656133 | 0.86 | TYR (0.69) | POLBTYRSLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10927283-B2 | Friction-reducing compositions for use in drilling operations | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-02-23 | — | — | US | disclosed |
| US-20180179432-A1 | Friction-Reducing Compositions for Use in Drilling Operations | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-06-28 | — | — | US | disclosed |
| US-20180179431-A1 | Friction-Reducing Compositions for Use in Drilling Operations | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-06-28 | — | — | US | disclosed |
| US-20180179432-A1 | Friction-Reducing Compositions for Use in Drilling Operations | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-06-28 | — | — | US | disclosed |
| US-20180179431-A1 | Friction-Reducing Compositions for Use in Drilling Operations | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-06-28 | — | — | US | disclosed |
| US-8937167-B2 | Compounds and methods for treating bacterial infections | WASHINGTON UNIVERSITY (US) | 2015-01-20 | — | — | US | disclosed |
| US-8937167-B2 | Compounds and methods for treating bacterial infections | WASHINGTON UNIVERSITY (US) | 2015-01-20 | — | — | US | disclosed |
| US-8937167-B2 | Compounds and methods for treating bacterial infections | WASHINGTON UNIVERSITY (US) | 2015-01-20 | — | — | US | disclosed |
| US-20120309701-A1 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | THE WASHINGTON UNIVERSITY (US) | 2012-12-06 | — | — | US | disclosed |
| US-20120309701-A1 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | THE WASHINGTON UNIVERSITY (US) | 2012-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309701-A1 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | MMP8, ELANE, GUSB | POLB 1082/4885EPHX2 1203/4885TYR 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.